| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.8 |